Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 450/DME/KMC | Other Identifier | Instititional Ethical and Review Board (IERB) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema
Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema. Those patients who had glaucoma history or IOP above 21 mm of Hg, Phakic, corneal opacity, vitreous hemorrhage, proliferative diabetic retinopathy, already received anti-VEGF injections, history of pan-retinal photocoagulation for proliferative diabetic retinopathy.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intravitreal Bevacizumab alone for center involving diabetic macular edema | Experimental | Effect of intravitreal Bevacizumab 1.25mg on center involving diabetic macular edema |
|
| Suprachoroidal triamcinolone acetonide and intravitreal Bevacizumab | Experimental | Combination of suprachoroidal triamcinolone acetonide and intravitreal Bevacizumab for the treatment of diabetic macular edema |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intravitreal Bevacizumab IVB | Drug | Intravitreal bevacizumab alone |
|
| Measure | Description | Time Frame |
|---|---|---|
| Central macular thickness | Effect of both treatment on central macular thickness measure on optical coherence tomography | 3 months |
| Visual Acuity | Improvement in best corrected visual acuity | 3 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Khyber Teaching Hospital | Peshawar | Khyber Pakhtunkhwa | 25000 | Pakistan |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 42369925 | Derived | Ahmad I, Mahsood YJ. Suprachoroidal Triamcinolone Plus Intravitreal Bevacizumab Versus Bevacizumab Alone for Diabetic Macular Edema in Pseudophakic Eyes: A randomized controlled trial. Pak J Med Sci. 2026 Jun;42(6):1377-1382. doi: 10.12669/pjms.42.6.14576. |
| Label | URL |
|---|---|
| Suprachoroidal injection of triamcinolone acetonide plus intravitreal bevacizumab in diabetic macular edema: a randomized pilot trial | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| intravitreal bevacizumab and suprachoroidal triamcinolone acetonide | Drug | Combination of Intravitreal bevacizumab and suprachoroidal triamcinolone acetonide |
|